Table 2.
Patient demographics, operation data and baseline hemodynamics
| Dexmedetomidine (n = 35) | Placebo (n = 31) | |
|---|---|---|
| Men | 31 | 28 |
| Women | 4 | 3 |
| Age (years) | 59.5 ± 8.5 | 62.4 ± 7.0 |
| Weight (kg) | 83.7 ± 11.9 | 79.7 ± 8.7 |
| Body surface area (m2) | 1.97 ± 0.17 | 1.92 ± 0.11 |
| Systolic blood pressure (mmHg) | 142 ± 21 | 138 ± 21 |
| Diastolic blood pressure (mmHg) | 73 ± 11 | 71 ± 9 |
| Heart rate (beats/min) | 61 ± 13 | 60 ± 7 |
| ASA grade | ||
| III | 2 | 0 |
| IV | 33 | 31 |
| NYHA classification | ||
| II | 12 | 12 |
| III | 22 | 17 |
| IV | 1 | 2 |
| Operation time (min) | 213 ± 55 | 190 ± 38 |
| Perfusion time (min) | 107 ± 29 | 96 ± 22 |
| Number of grafts | 3 ± 0.7 | 3 ± 0.6 |
| Time to extubation (min) | 1114 ± 248 | 1193 ± 283 |
Data are presented as number of subjects or mean ± SD. Data are based on the per-protocol cohort (n = 66). ASA = American Society of Anesthesiologists; NYHA = New York Heart Association.